Researchers has demonstrably improved the development of a novel treatment for amyloid heart disease, employing the compound. Initial clinical results suggests potential improvements for patients suffering by a debilitating condition. This focus represents BridgeBio's dedication to managing significant patient needs in this heart space. Attruby: B